Skip to main content

Table 1 Associations between the expression of miR-148b with clinicopathological features in 106 patients with gastric cancer

From: MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

  n miR-148b a
Sex   
   Male 80 0.28(0.08-1.26)
   Female 26 0.47(0.25-1.24)
P   0.272
Age (years)   
   ≤65 65 0.41(0.10-1.24)
   > 65 41 0.27(0.08-1.26)
P   0.500
Tumor size (cm)   
   < 6 73 0.46(0.13-1.47)
   ≥6 33 0.23(0.05-0.43)
P   0.027*
Macroscopic type   
   Early stage 3 1.82(1.67-1.85)
   Borrmann I+II 9 0.50(0.26-1.01)
   Borrmann III+IV 94 0.31(0.08-1.16)
P   0.098
Histologic grade   
   Good 23 0.31(0.10-0.61)
   Poor 83 0.41(0.08-1.28)
P   0.626
pT stage   
   T1+T2 51 0.39(0.09-1.27)
   T3+T4 55 0.36(0.08-1.23)
P   0. 985
pN stage   
   N0 25 0.28(0.08-0.69)
   N1 34 0.39(0.08-0.94)
   N2 29 0.47(0.20-1.70)
   N3 18 0.17(0.05-0.64)
P   0.171
pTNM stage   
   I 20 0.35(0.09-0.66)
   II 22 0.33(0.08-0.94)
   III 39 0.43(0.17-1.27)
   IV 25 0.27(0.06-3.13)
P   0.821
Invasion into lymphatic vessels   
   Negative 77 0.41(0.10-1.30)
   Positive 29 0.27(0.06-1.00)
P   0.346
  1. a Median of relative expression, with 25th-75th percentile in parenthesis.
  2. *Indicated statistical significance (P < 0.05).